Implantation and preliminary follow‐up of the Bard Valeo stent in pulmonary artery stenosis
Authors:
- 15 February 2014
- journal article
- pediatric and-congenital-heart-disease
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 84 (2) , 197-203
Abstract
Objectives To evaluate the performance of the Bard Valeo stent in pulmonary artery stenoses. Background The premounted Valeo stent requires only 6–7 French access and can be post-dilated to 20 mm on bench testing. Although it appears ideal for implantation in pulmonary artery stenoses in children, it has been unclear whether it has sufficient radial strength to prevent vessel recoil and stent collapse. Methods Twelve stents were implanted in 10 patients aged 1.2–19.9 years (weight 9.9–54 kg). Implant results were assessed retrospectively. Results All implants were successful with no complications. The stent tracked easily and was readily visible on fluoroscopy. The median (range) diameter of the pulmonary artery stenosis increased from 4.9 (1.8–7.4) mm to 9 (6–10.6) mm (P ≤ 0.01), the median peak to peak systolic pressure gradient across the pulmonary artery stenosis decreased from 16 (11–66) mmHg to 6 (0–10) mmHg (P ≤ 0.01), and the right ventricle to systemic blood pressure ratio fell from 0.72 (0.54–1.1) to 0.54 (0.28–0.69) (P ≤ 0.01). Median stent recoil was 5.5 (0–21)%. Jailed side branches remained patent. Nine stents were assessed fluoroscopically on 11.5 (0–30) month follow-up. There were no stent fractures. 6 stents were not distorted, 2 had minor distortion, and 1 stent, implanted in a highly resistant lesion, had moderate distortion. Conclusions The Valeo stent is low profile, conformable, and easy to deliver, even in small children. It has adequate radial strength to stent pulmonary artery stenoses with minimal recoil. It maintains its geometry on medium term follow up in compliant lesions. Resistant stenoses may distort the stent.Keywords
This publication has 14 references indexed in Scilit:
- A novel biodegradable stent applicable for use in congenital heart disease: Bench testing and feasibility results in a rabbit modelCatheterization and Cardiovascular Interventions, 2013
- Ultra-High-Pressure Balloon Angioplasty for Treatment of Resistant Stenoses Within or Adjacent to Previously Implanted Pulmonary Arterial StentsCirculation: Cardiovascular Interventions, 2009
- Feasibility and efficacy of stent redilatation in aortic coarctationCatheterization and Cardiovascular Interventions, 2008
- Stent implantation is effective treatment of vascular stenosis in young infants with congenital heart disease: Acute implantation and long‐term follow‐up resultsCatheterization and Cardiovascular Interventions, 2008
- Early restenosis following biodegradable stent implantation in an aortopulmonary collateral of a patient with pulmonary atresia and hypoplastic pulmonary arteriesCatheterization and Cardiovascular Interventions, 2007
- Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newbornCatheterization and Cardiovascular Interventions, 2006
- First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm babyCatheterization and Cardiovascular Interventions, 2005
- The efficacy and safety of stent redilatation in congenital heart diseaseHeart, 2003
- A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal---results 6-18 months after implantation into New Zealand white rabbitsHeart, 2001
- Use of endovascular stents in congenital heart disease.Circulation, 1991